https://www.selleckchem.com/pr....oducts/iberdomide.ht
Pain (35%), nausea (30%), sleeping difficulty (29%), and fatigue (22%) were the most commonly reported symptoms in children receiving HSCT. Children in the HSCT cohort had similar total, subscale, and individual symptom scores compared with children who did not receive HSCT. Certain domains of gastrointestinal symptoms (nausea, lack of appetite, and diarrhea) were higher for children receiving HSCT compared with children with advanced cancer not receiving HSCT (p less then .05). Conclusion Elicitation of patient-reported symptom expe
Мне нравится
Комментарий
Перепост
